5HDO
Crystal structure of a nanobody raised against urokinase-type plasminogen activator
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | BESSY BEAMLINE 14.1 |
Synchrotron site | BESSY |
Beamline | 14.1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2013-06-07 |
Detector | PSI PILATUS 6M |
Wavelength(s) | 0.98 |
Spacegroup name | P 43 21 2 |
Unit cell lengths | 99.830, 99.830, 127.330 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 47.277 - 2.160 |
R-factor | 0.1786 |
Rwork | 0.177 |
R-free | 0.21770 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4jvp |
RMSD bond length | 0.007 |
RMSD bond angle | 1.093 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHENIX |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.280 | 2.237 |
High resolution limit [Å] | 2.160 | 2.160 |
Rmerge | 0.085 | 0.690 |
Number of reflections | 35146 | |
<I/σ(I)> | 22.42 | 4.18 |
Completeness [%] | 99.9 | 99.88 |
Redundancy | 14.5 | 14.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 289 | 0.1M MES, 0.2M ammonium sulphate, 30% w/v PEG 5000 |